L’impiego dell’intelligenza artificiale (IA) nella diagnosi del melanoma cutaneo
TMT Peer reviews · 2026
DOI: 10.63648/0dcr8h73 ↗Kurz gefasst
Fachartikel in der Zeitschrift TMT Peer reviews, 2026. Verfasst von Ylenia Micca und 2 weiteren Autor:innen.
Abstract (Originalsprache)
Artificial intelligence (AI) is reshaping melanoma diagnosis through convolutional neural networks (CNNs), achieving accuracy comparable to, and sometimes exceeding, that of expert dermatologists. Prospective studies and systematic reviews highlight the benefits of Augmented Intelligence, combining algorithmic output with clinical judgment to enhance sensitivity and specificity. Nonetheless, important limitations persist, including dataset bias, underrepresentation of darker skin types, and insufficient external validation. Ethical, regulatory, and trust-related issues remain critical. Overall, AI represents a promising support tool in dermatology, but requires transparency, robust clinical validation, and specialist supervision to ensure safe and responsible integration into clinical practice.
Zitieren
APA
Micca, Y., Calegari, M., & Beltraminelli, H. (2026). L’impiego dell’intelligenza artificiale (IA) nella diagnosi del melanoma cutaneo. TMT Peer reviews. https://doi.org/10.63648/0dcr8h73
Vancouver
Micca Y, Calegari M, Beltraminelli H. L’impiego dell’intelligenza artificiale (IA) nella diagnosi del melanoma cutaneo. TMT Peer reviews. 2026. doi:10.63648/0dcr8h73
BibTeX
@article{Micca2026,
author = {Micca, Ylenia and Calegari, Matteo and Beltraminelli, Helmut},
title = {L’impiego dell’intelligenza artificiale (IA) nella diagnosi del melanoma cutaneo},
journal = {TMT Peer reviews},
year = {2026},
doi = {10.63648/0dcr8h73}
}
EUVIMED